Summary
Immunoreactive oxytocin (OXT) and arginine8-vasopressin (AVP) levels were measured in limbic areas of the mouse brain (hippocampus, amygdala and basal forebrain). Peptides were measured by radioimmunoassay (RIA). Acute morphine treatment caused a naloxone-reversible increase in OXT content in all three brain regions. The AVP contents of the same brain areas, on the other hand, were not affected by acute morphine treatment. In mice rendered tolerant to/dependent on morphine with subcutaneous morphine pellets, the OXT levels in the limbic brain structures were in the control range (basal forebrain and amygdala) or even decreased (hippocampus). In the latter brain structure of the tolerant animals, the AVP content was also decreased. Naloxone-precipitated withdrawal syndrome in the tolerant/dependent animals resulted in abrupt increases in the OXT and AVP levels of the hippocampus and in the OXT content of the basal forebrain structures.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brinton RE, Wamsley JK, Gee KW, Wam YP, Yamamura HI (1984) (3H) Oxytocin binding sites in the rat brain demonstrated by quantitative light microscopic autoradiography. Eur J Pharmacol 102: 365–367
Buijs RM (1983) Vasopressin and oxytocin —their role in neurotransmission. Pharmacol Ther 22: 127–141
Buijs RM, Van Heerikhuize JJ (1982) Vasopressin and oxytocin release in the brain: a synaptic event. Brain Res 252: 71–76
De Kloet ER, Rotteveel F, Voorhuis TAM, Terlou M (1985) Topography of binding sites for neurohypophyseal hormones in rat brain. Eur J Pharmacol 110: 113–119
Dogterom J, Van Wimersma Greidanus TjB, Swaab DF (1977) Evidence for the release of Vasopressin and oxytocin into cerebrospinal fluid: measurements in plasma and CSF of intact and hypophysectomized rats. Neuroendocrinology 24: 108–118
Hawthorn J, Ang VTY, Jenkins JS (1984) Comparison of the distribution of oxytocin and Vasopressin in the rat brain. Brain Res 307: 289–294
Kovács GL, Borthaiser Z, Telegdy G (1985c) Oxytocin reduces intravenous heroin self-administration in heroin-tolerant rats. Life Sci 37: 17–26
Kovács GL, Faludi M, Telegdy G (1985b) Oxytocin diminishes heroin tolerance in mice. Psychopharmacology 86: 377–379
Kovács GL, Horváth Z, Sarnyai Z, Faludi M, Telegdy G (1985a) Oxytocin and a C-terminal derivative (Z-prolyl-D-leucine) attenuate tolerance to and dependence on morphine and interact with dopaminergic neurotransmission in the mouse brain. Neuropharmacology 24: 413–419
Kovács GL, Izbéki F, Horváth Z, Telegdy G (1984) Effects of oxytocin and a derivative (Z-prolyl-D-leucine) on morphine tolerance/dependence are mediated by the limbic system. Behav Brain Res 14: 1–8
Kovács GL, Sarnyai Z, Szabó G, Telegdy G (1986) Development of morphine tolerance is under tonic control of brain oxytocin. Drug Alcohol Dep 17: 369–375
Kovács GL, Szontágh L, Baláspiri L, Hódi K, Bohus P, Telegdy G (1981) On the mode of action of an oxytocin derivative (Z-pro-D-leu—) on morphine dependence in mice. Neuropharmacology 20: 647–651
Kovács GL, Van Ree JM (1985) Behaviorally active oxytocin fragments simultaneously attenuate heroin self-administration and tolerance in rats. Life Sci 37: 1895–1900
Kovács GL, Vecsernyés M, Laczi F, Faludi M, Telegdy G, László FA (1985d) Acute morphine treatment and morphine tolerance/dependence alter immunoreactive oxytocin levels in the mouse hippocampus. Brain Res 328: 158–160
Krivoy WA, Zimmermann E, Lande S (1974) Facilitation of development of resistance to morphine analgesia by desglycinamide9-lysine vasopressin. Proc Natl Sci USA 71: 1852–1856
Laczi F, Gaffori O, De Kloet ER, De Wied D (1983a) Differential response in immunoreactive arginine-vasopressin content of microdissected brain regions during passive avoidance behavior. Brain Res 260: 342–346
Laczi F, Gaffori O, De Kloet ER, De Wied D (1983b) Argininevasopressin content of hippocampus and amygdala during passive avoidance behavior in rats. Brain Res 280: 309–315
Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193: 265–275
Sawchenko PE, Swanson LW (1985) Relationship of oxytocin pathways to the control of neuroendocrine and autonomic function. In: Amico JA, Robinson AG (eds) Oxytocin: clinical and laboratory studies. Elsevier, Amsterdam, pp 87–103
Slotnick BM, Leonard CM (1975) A stereotaxic atlas of the albino mouse forebrain. Public Health Service Publication No (ADM) 75–100, US Government Printing Office, Washington DC
Van Beek-Verbeek G, Fraenkel HM, Van Ree JM (1983) DesGly9-(Arg8)-vasopressin may facilitate methadone detoxification of heroin addicts. Subst Alcohol Act Miss 4: 375–382
Van Ree JM, De Wied D (1977b) Effect of neurohypophyseal hormones on morphine dependence. Psychoneuroendocrinology 2: 35–41
Van Wimersma Greidanus TjB, Ten Haaf JA (1984) Opioids and the posterior pituitary. In: Delitalia G, Motta M, Serio M (eds) Opioid modulation of endocrine function. Raven Press, New York, pp 125–136
Van Wimersma Greidanus TjB, Ten Haaf JA (1985) The effects of opiates and opioid peptides on oxytocin release. In: Amico JA, Robinson AG (eds) Oxytocin: clinical and laboratory studies. Elsevier, Amsterdam, pp 145–153
Way EL, Loh HH, Shen FH (1969) Simultaneous quantitative assessment of morphine tolerance and physical dependence. J Pharmacol Exp Ther 167: 1–8
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kovács, G.L., Laczi, F., Vecsernyés, M. et al. Limbic oxytocin and arginine8-vasopressin in morphine tolerance and dependence. Exp Brain Res 65, 307–311 (1987). https://doi.org/10.1007/BF00236302
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00236302